Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance

Transplantation

Volumn 95, Issue 2, 2013, Pages 301-308

  Xu, Hong ^a   Ramsey, Deborah M ^a   Wu, Shengli ^a   Bozulic, Larry D ^a   Ildstad, Suzanne T ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Regenerex LLC   (United States)

Author keywords

Mixed chimerism; Nonmyeloablative conditioning; Regulatory T cells.; Tolerance; Vascularized composite allotransplantation

Indexed keywords

ALPHA BETA T LYMPHOCYTE RECEPTOR MONOCLONAL ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DONOR; FEMALE; GRAFT RECIPIENT; HINDLIMB; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MALE; MYOCUTANEOUS FLAP; NONHUMAN; NONMYELOABLATIVE CONDITIONING; OSTEOCUTANEOUS FLAP; PRIORITY JOURNAL; RADIATION DOSE; RAT; REGULATORY T LYMPHOCYTE; SHORT COURSE THERAPY; SKIN GRAFT; TRANSPLANTATION TOLERANCE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; WHOLE BODY RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG THERAPY, COMBINATION; FREE TISSUE FLAPS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; RATS; RATS, INBRED ACI; RATS, INBRED WF; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; WHOLE-BODY IRRADIATION;

EID: 84872968851     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827899fc     Document Type: Article

References (36)

1. Tobin GR, Breidenbach WC III, Ildstad ST, et al. The history of human composite tissue allotransplantation. Transplant Proc 2009; 41: 466.
2. Swearingen B, Ravindra K, Xu H, et al. The science of composite tissue allotransplantation. Transplantation 2008; 86: 627.
3. Breidenbach WC, Gonzales NR, Kaufman CL, et al. Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg 2008; 33: 1039.
4. Wu S, Xu H, Ravindra K, et al. Composite tissue allotransplantation: past, present and futureVthe history and expanding applications of VCA as a new frontier in transplantation. Transplant Proc 2009; 41: 463.
5. Ravindra KV, Wu S-L, Bozulic L, et al. Composite tissue transplantation: a rapidly advancing field. Transplant Proc 2008; 40: 1237.
6. Ravindra KV, Xu H, Ildstad ST. Vascularized composite allotransplantation at a crossroad. Transplant Proc 2011; 43: 3501.
7. Pan H, Zhao K, Wang L, et al. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. J Surg Res 2010; 160: 315.
8. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
9. Rahhal D, Xu H, Huang WC, et al. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation 2009; 88: 773.
10. Yu P, Xiong S, He Q, et al. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts. Immunology 2009; 127: 500.
11. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
12. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerismafter renal and hematopoietic-cell transplantation.NEngl JMed 2008; 358: 362.
13. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transpl Med 2012; 4: 124ra28.
14. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
15. Colson YL, Lange J, Fowler KJ, et al. Mechanism for co-tolerance in nonlethally conditioned mixed chimeras: negative selection of the VA T-cell receptor repertoire by both host and donor bone marrowderived cells. Blood 1996; 88: 4601.
16. Mueller DL.Mechanisms maintaining peripheral tolerance. Nat Immunol 2010; 11: 21.
17. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009;30: 656.
18. Sanchez-Fueyo A, Domenig CM, Mariat C, et al. Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation. Transpl Int 2007; 20: 534.
19. Tsang JY, Tanriver Y, Jiang S, et al. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008; 118: 3619.
20. Amarnath S, Costanzo CM,Mariotti J, et al. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol 2010; 8: e1000302.
21. Adeegbe D, Levy RB, Malek TR. Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance. Blood 2010; 115: 1932.
22. Blache C, Chauvin JM, Marie-Cardine A, et al. Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations. Biol Blood Marrow Transplant 2010; 16: 430.
23. Colson YL, Zadach K, Nalesnik M, et al. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995; 60: 971.
24. Billingham RE, Brent L, Brown JB, et al. Time of onset and duration of transplantation immunity. Transplant Bull 1959; 6: 410.
25. Graff RJ, Silvers WK, Billingham RE, et al. The cumulative effect of histocompatibility antigens. Transplantation 1966; 4: 605.
26. Foster RD, Pham S, Li S, et al. Long-termacceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 2003; 76: 988.
27. Prabhune KA, Gorantla VS, Perez-Abadia G, et al. Composite tissue allotransplantation in chimeric hosts: part II. A clinically relevant protocol to induce tolerance in a rat model. Transplantation 2003; 76: 1548.
28. Gorantla VS, Prabhune KA, Perez-Abadia G, et al. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graftversus- host disease. Transplantation 2003; 75: 922.
29. Farris AB, Taheri D, Kawai T, et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant 2011; 11: 1464.
30. Pham SM, Rao AS, Zeevi A, et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000; 119: 673.
31. Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism and graft acceptance. Lancet 1992; 339: 1579.
32. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hepatology 1993; 17: 1127.
33. McSherry C, Hertz MI, Jackson AM, et al. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. Clin Transplant 1995; 9: 442.
34. Corry RJ, Chakrabarti PK, Shapiro R, et al. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg 1999; 230: 372.
35. Bonilla WV, Geuking MB, Aichele P, et al. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006; 116: 156.
36. Bozulic LD,Wen Y, Xu H, et al. Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Transplantation 2011; 91: 908.